A Day Up For Avalo Therapeutics Inc.
Thu, Mar 28, 2024 at 07:19 PM
Avalo Therapeutics Inc. (AVTX:NASDAQ) rocketted at $21.75, representing a gain of 357.9%. On Thu, Mar 28, 2024, AVTX:NASDAQ touched a New 2-Week High of $21.75. The stock appeared on our News Catalysts scanner on Wed, Mar 27, 2024 at 07:15 PM in the 'PRIVATE PLACEMENT' category. From Thu, Mar 14, 2024, the stock recorded 60.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Mar 28, 2024 at $34.46 with a volume of 31M+.
About Avalo Therapeutics Inc. (AVTX:NASDAQ)
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in...
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 375%
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 357.89%
- Biodexa Pharmaceuticals plc Sponsored ADR (New) 2023 (BDRX:NASDAQ), 88.59%
- CERo Therapeutics Holdings Inc Com (CERO:NASDAQ), 88.34%
- Nexalin Technology Inc. (NXL:NASDAQ), 79.49%
- two Class A (TWOA:NYSE), 71.47%
- X3 Holdings Co Ltd Ord (New) US $ 0.40 (XTKG:NASDAQ), 70.53%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 69.01%
- Keyarch Acquisition Corporation (KYCH:NASDAQ), 67.35%
- Vinco Ventures Inc. (BBIG:NASDAQ), 60%